
|Videos|September 12, 2017
Early Diagnosis of Multidrug-Resistant Pneumonia Benefits Patient Outcomes
Author(s)Contagion® Editorial Staff
Alan Gross, PharmD, shares how an early diagnosis of multidrug-resistant pneumonia can work towards improving patient outcomes.
Advertisement
Alan Gross, PharmD, BCPS-AQID, Clinical Assistant Professor, Pharmacy Practice, University of Illinois at Chicago, College of Pharmacy, shares how early diagnosis of multidrug-resistant pneumonia can improve patient outcomes. With early diagnosis, health care providers can avoid using broad-spectrum antibiotics and prove a more effective targeted treatment.
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contagion Live
1
Pritelivir Improves Outcomes in Immunocompromised Patients With Refractory Herpes Simplex Virus
2
Measles Update: February 6, 2026
3
Antibiotics Deconstructed: IV Fosfomycin
4
HIV in the Black Community: Shifting from Stigma and Health Inequalities to Communication and Care Initiatives
5

































































































































